Enlivex Ltd (ENLV)

May 25, 2026

ENLV Q4 2025 Earnings: Significant EPS Miss Amid Development Stage CostsProfit Cycle Analysis - Newser

May 25, 2026

May 23, 2026

Enlivex Ltd. (ENLV) Slides Slightly as Shares Hover Near Key Support LevelFear Greed Index - Newser

May 23, 2026

May 22, 2026

Enlivex Ltd expected to post a loss of 2 cents a shareEarnings Preview - TradingView

May 22, 2026

May 22, 2026

Enlivex (ENLV) Edges Higher After Testing Key Support at $0.69Ichimoku TK Cross - Newser

May 22, 2026

May 21, 2026

ENLV Q1'26 Earnings: EPS estimate is (0.02) USD - TradingView

May 21, 2026

May 18, 2026

Enlivex Doses First US Patient in Phase 2b Knee Osteoarthritis Trial - Moomoo

May 18, 2026

May 18, 2026

Enlivex (ENLV) Begins Phase 2b Clinical Trial for Osteoarthritis Treatment - GuruFocus

May 18, 2026

May 18, 2026

Enlivex doses first U.S. patient in knee osteoarthritis trial - Investing.com UK

May 18, 2026

May 18, 2026

Enlivex Doses First U.S. Patient in Phase 2b Allocetra Trial for Knee Osteoarthritis - TipRanks

May 18, 2026

May 18, 2026

Enlivex doses first U.S. patient in knee osteoarthritis trial By Investing.com - Investing.com Canada

May 18, 2026

May 18, 2026

Enlivex Announces Dosing Of First Patient In The United States As Part Of Its Phase 2b Trial of Allocetra in Age-Related Primary Moderate-to-Severe Knee Osteoarthritis - The Manila Times

May 18, 2026

May 18, 2026

First U.S. patient dosed in Enlivex (Nasdaq: ENLV) Phase 2b knee OA trial - Stock Titan

May 18, 2026

May 18, 2026

Enlivex Ltd Announces Dosing of First Patient in the United States as Part of Phase 2B Trial of Allocetra in Age-Related Primary Moderate-To-Severe Knee Osteoarthritis - marketscreener.com

May 18, 2026

May 15, 2026

Enlivex receives Nasdaq minimum bid price deficiency notice - Investing.com India

May 15, 2026

May 15, 2026

Enlivex Faces Nasdaq Minimum Bid Price Deficiency After Shares Fall Below $1 Threshold - TipRanks

May 15, 2026

May 15, 2026

Enlivex receives Nasdaq minimum bid price deficiency notice By Investing.com - Investing.com South Africa

May 15, 2026

May 15, 2026

Enlivex announces receipt of Nasdaq minimum bid price notification - marketscreener.com

May 15, 2026

May 15, 2026

Enlivex Announces Receipt of Nasdaq Minimum Bid Price Notification - The Manila Times

May 15, 2026

May 15, 2026

Enlivex Ltd. Receives Nasdaq Notice for Minimum Bid Price Non-Compliance - Quiver Quantitative

May 15, 2026

May 15, 2026

Enlivex (NASDAQ: ENLV) gets Nasdaq notice over sub-$1 bid price and listing risk - Stock Titan

May 15, 2026

May 15, 2026

ENLV Q1'26 Earnings: revenue estimate is 0 USD - TradingView

May 15, 2026

May 12, 2026

Enlivex Therapeutics stock (IL0011283620): Recent price drop and analyst views - AD HOC NEWS

May 12, 2026

May 12, 2026

Enlivex advances Allocetra while expanding into prediction markets - Proactive financial news

May 12, 2026

May 12, 2026

TradingKey - TradingKey

May 12, 2026

May 01, 2026

Enlivex Ltd. (NASDAQ: ENLV) registers 23.33M shares for resale by noteholder - Stock Titan

May 01, 2026

May 01, 2026

Enlivex Ltd Share PriceENLV, RNS News, Articles, Quotes, & Charts (NASDAQ:ENLV) - Proactive financial news

May 01, 2026

Apr 30, 2026

Enlivex Treasury Portfolio Update: Listing of the RAIN Token on HTX, a Leading Cryptocurrency Exchange - The Manila Times

Apr 30, 2026

Apr 30, 2026

Enlivex’s $567M RAIN treasury asset gains a new market on HTX - Stock Titan

Apr 30, 2026

Apr 28, 2026

Enlivex Treasury Update: Total RAIN Holdings Rise to 78,819,756,062 Tokens as of April 27, 2026, Representing an Aggregated Value of $567 Million - The Manila Times

Apr 28, 2026

Apr 28, 2026

Enlivex Ltd.: Enlivex Treasury Update: Total RAIN Holdings Rise to 78,819,756,062 Tokens as of April 27, 2026, Representing an Aggregated Value of $567 Million - FinanzNachrichten.de

Apr 28, 2026

Apr 28, 2026

$567M in RAIN: Enlivex taps option priced 55% below April 27 close - Stock Titan

Apr 28, 2026

Apr 26, 2026

Enlivex Therapeutics (ENLV) price target decreased by 30.00% to 7.14 - MSN

Apr 26, 2026

Apr 25, 2026

Enlivex Therapeutics (NASDAQ:ENLV) Stock Rating Upgraded by Wall Street Zen - MarketBeat

Apr 25, 2026

Apr 23, 2026

Enlivex (ENLV) price target increased by 53.85% to 20.40 - MSN

Apr 23, 2026

Apr 23, 2026

ENLV (Enlivex Ltd. Ordinary Shares) posts sharply wider Q4 2025 loss than expected, shares drop 3.26% on dismal earnings.Barrier to Entry - Cổng thông tin điện tử Tỉnh Sơn La

Apr 23, 2026

Apr 23, 2026

Enlivex to Present Phase IIa 3-month and 6-month Data of Allocetra at OARSI 2026 World Congress - The Manila Times

Apr 23, 2026

Apr 23, 2026

New knee osteoarthritis data from Enlivex heads to OARSI 2026 - Stock Titan

Apr 23, 2026

Apr 22, 2026

Enlivex receives Danish approval for knee osteoarthritis trial By Investing.com - Investing.com India

Apr 22, 2026

Apr 21, 2026

Enlivex Ltd.: Fundamental Analysis and Financial Ratings | ENLV | IL0011319527 - marketscreener.com

Apr 21, 2026

Apr 21, 2026

Enlivex Ltd. (ENLV) registers 23.3M conversion shares from $21M note - Stock Titan

Apr 21, 2026

Apr 21, 2026

Enlivex (ENLV) Secures Approval for Phase 2b Osteoarthritis Clin - GuruFocus

Apr 21, 2026